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Abstract
We present the case of 80-year-old male with superficial papillary urothelial carcinoma of the
urinary bladder with striking multicystic architecture with a combination of features of urothelial
carcinoma with gland-like lumina, with signet-ring cell differentiation and microcystic pattern.
However, the tumor shared the morphologic features of several variants of urothelial carcinoma,
the most important differential diagnosis covered so-called florid Brunneriosis, cystitis cystica, and
primary adenocarcinomas of the urinary bladder.
Background
Urothelial carcinomas, particularly high-grade tumors,
may show divergent differentiation. Urothelial carcino-
mas with true glandular differentiation must be distin-
guished from urothelial carcinomas with gland-like
lumina. The latter represents microcystic change within
otherwise typical urothelial carcinoma. Although these
spaces may contain mucin, they differ from urothelial car-
cinoma admixed with a well-defined adenocarcinoma
component [1].
Glandular neoplasms arising in the urinary bladder are an
uncommon but generally recognized category of tumors.
Approximately 2% of primary carcinomas in this organ
account for non urachal adenocarcinomas with or with-
out mucus production, including signet ring cell carcino-
mas [2,3]. We present a case of low-grade papillary
urothelial carcinoma characterized by striking degrees of




An 80-year-old male, a heavy smoker, was admitted to the
hospital due to hematuria. Cystoscopy revealed multiple
superficial small tumors ranged in size from 0.4–2 cm.
Transurethral resection was performed and subsequent
local chemotherapy by Mitomycin followed. The patient
underwent cystoscopic resection of three recidiving super-
ficial tumors 1 year later. The patient was alive and well
without sign of disease 3 years after the second surgery.
Pathologic Findings
The primary tumor was characterized by multicystic and
papillary architecture and the presence of gland formation
(Figure 1). Cysts were lined with urothelial cells. Some
areas had columns of cells arranged concentrically around
eosinophilic PAS (periodic acid shiff)-positive material-
filled gland spaces (Figure 2). Additionally, numerous sig-
net-ring cells were present in some parts (Figure 3). Areas
with gland-like lumina formation were also noted. Mor-
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primary lesion.
Tissue for light microscopy was fixed in 4% formaldehyde
and embedded in paraffin using routine procedure. Sec-
tions 5-μm thick were cut from the tissue blocks and
stained with hematoxylin and eosin, and periodic acid
Schiff (PAS). Immunohistochemical staining was per-
formed using the following primary monoclonal antibod-
ies: cytokeratins AE1–AE3 (NeoMarkers, Fremont, CA,
USA), CAM 5.2 (Becton Dickinson, San Jose, CA, USA),
CK 7 (DakoCytomation, Glostrup, Denmark), CK 20
(DakoCytomation), LeuM1 (Becton Dickinson), cyclin
D1 (DakoCytomation), carcinoembryonal antigen
(DakoCytomation), cerb2 (Novocastra, Newcastle, U.K.),
p53 (DakoCytomation), EGFR (DakoCytomation),
MUC1 (Novocastra), MUC2 (Novocastra), and polyclo-
nal antibody Ki 67 (DakoCytomation). Primary antibod-
ies were visualized using the supersensitive streptavidin-
biotin-peroxidase complex (Biogenex, San Ramon, CA,
USA). Appropriate positive control tissues used with the
primary antibodies were employed.
Moderate to strong immunoreactivity was noted for
cytokeratins (CK 7, CK 20, AE1–AE3, CAM 5.2) (Figure 4
and 5), LeuM1, and cyclin, while strong but focal reactiv-
ity was revealed for CEA, cerb2 and weak focal positivity
for p53. Negative reaction for epidermal growth factor
receptor (EGFR) was found. The expression of MUC1 and
MUC2 was strongly positive. Positive staining was
restricted to either small- or intermediate-size cysts or
extended to signet-ring cells, in which reactivity was pre-
dominantly cytoplasmic.
Conclusion
Normal urothelial cells possess the capacity to produce
mucoid substances [4]. Diffuse and globular mucoprotein
deposits in urothelial cells have also been described [5].
The ability of urothelial cells to secrete mucin in chronic
urocystitis with and without glandular metaplasia and in
adenocarcinomas or signet-ring cell carcinomas of the uri-
nary bladder is well-known [6]. On the other hand,
urothelial bladder carcinoma exhibits diverse microscopic
appearances. Foci of glandular metaplasia are common,
The primary tumor was characterized by multicystic and pap-illary architecture and the p esence of gland formatio  (hem toxylin-eosin)Figure 1
The primary tumor was characterized by multicystic 
and papillary architecture and the presence of gland 
formation (hematoxylin-eosin).
Cysts were lined with urothelial cells arranged around eosi-nophilic PAS (periodic acid shiff)-positive material-fille  gland spaces (hematoxylin-eosin)Figure 2
Cysts were lined with urothelial cells arranged 
around eosinophilic PAS (periodic acid shiff)-positive 
material-filled gland spaces (hematoxylin-eosin).
Numerous signet-ring cells were present in walls of cysts (he at xylin-eosin)Figure 3
Numerous signet-ring cells were present in walls of 
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vacuoles [7].
Tumor cells in our case expressed the apomucins MUC1
and MUC2 Several mucin genes designated MUC genes
have been identified [8]. Previous studies have shown that
MUC1 mucin protein is strongly expressed by urothelial
cells. Walsh et al. examined the presence of MUC1 and -2
in normal and malignant urothelium and found that
MUC1 was expressed by both normal and malignant epi-
thelium, whereas MUC2 expression was found only in
urothelial carcinomas [7]. In colon carcinomas with
MUC1, gene products have been correlated with advanced
disease stage [9]; on the other hand, in bladder carcino-
mas there is no significant association between high
expression of MUC1 and histologic grade and also disease
stage [7]. MUC1 and -2 expression in our case was not cor-
related with poor prognosis, because both primary and
recidiving tumors were low-grade superficial urothelial
carcinomas.
Among a total of 100 cases of urothelial carcinomas, Don-
huijsen et al. found that 37 tumors revealed periodic-acid
Schiff-positive cytoplasmic inclusions [5]. These inclu-
sions were histochemically, immunohistochemically, and
ultrastructurally identified as cytoplasmic deposits of
mucoid materials, similar to our case.
There are several entities that should be considered in dif-
ferential diagnosis. The most important reactive cystic
change within the urothelium is the formation of von
Brunn nests. In so-called florid Brunneriosis [10] cyst for-
mation is more pronounced and involves a large number
of nest structures. Apical glandular differentiation and
eosinophilic secretion are also common, acquiring fea-
tures of cystitis cystica and cystitis glandularis. The case we
have described herein may show numerous cysts with
mucin secretion similar to cystitis cystica.
Several overlapping morphologic variants of urothelial
carcinoma with glandular appearance exist. The so-called
urothelial carcinoma with tubules is composed of small-
to medium-size urothelial cell-lined tubules. The growth
pattern of this tumor is mainly infiltrative; moreover, it
lacks the signet-ring elements and larger cystic spaces
present in our case [11,12].
Another very similar entity comprises microcystic urothe-
lial carcinoma. This type demonstrates cystic changes
within an otherwise typical urothelial carcinoma, or
urothelial carcinoma with glandular differentiation. Cysts
were rarely be filled with eosinophilic secretion similar to
our case. The cyst lining may be absent, flattened, urothe-
lial, or differentiated toward mucinous cells. Cysts in our
case were lined with urothelial cells; in addition, signet-
ring cells were present in the walls of cysts [11].
Urothelial carcinoma with gland-like lumina represents
another microcystic change within an otherwise typical
urothelial carcinoma. These luminal structures may con-
tain mucin [13]. We have found areas identical to this type
of urothelial carcinoma within the main tumor mass of
our case.
In conclusion, we present a case of superficial papillary
urothelial carcinoma with striking multicystic architec-
ture, with a combination of features of urothelial carci-
Tumor was diffusely positive for CK20 (cytokeratin 20)Figure 4
Tumor was diffusely positive for CK20 (cytokeratin 
20).
Tumor cells were also positive for CK7 (cytokeratin 7)Figure 5
Tumor cells were also positive for CK7 (cytokeratin 
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